Cingulate Announces Phase 3 CTx-1301 ADHD Data Published In Journal Of Child And Adolescent Psychopharmacology, With Placebo-Adjusted Effect Sizes Of 0.737 To 1.185
Share
Why It Matters
Cingulate shared test results for a medicine that helps kids with ADHD focus better, and the results were stronger than a fake pill. When a company publishes good study results in a real science journal, it can mean the medicine might be approved and sell well.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.